Researcher
Dehui Xu
- Keywords:Medicine
- Disciplines:Humanities and the arts, Engineering and technology, Natural sciences
Affiliations
- Hematology (Research group)
Member
From2 Feb 2017 → 31 Dec 2012 - Immunology and Microbiology (Department)
Member
From1 Apr 2009 → 31 Dec 2012 - Hematology (Research group)
Member
From1 Oct 2006 → 30 Sep 2011
Publications
1 - 10 of 17
- Design and Performance of the first IceAct Demonstrator at the South Pole(2020)
Authors: J. A. Aguilar, M. Ahrens, C. Alispach, K. Andeen, T. Anderson, G. Anton, C. Argüelles, T. C. Arlen, J. Auffenberg, S. Axani, et al.
- Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (vol 12, pg 1763, 2013)(2015)
Authors: Jinsong Hu, E Van Valckenborgh, Dehui Xu, Song Xu, Benjamin Van Camp, Damian R Handisides, Charles P. Hart
Pages: 1762-1762 - Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro.(2013)
Authors: Jinsong Hu, E Van Valckenborgh, Dehui Xu, Song Xu, Benjamin Van Camp, Damian R Handisides, Charles Hart
Pages: 1763-1773 - The role of Notch signaling in multiple myeloma(2013)
Authors: Dehui Xu, Jinsong Hu, E Van Valckenborgh
Pages: 77-95Number of pages: 19 - Dll1/Notch Interaction Contributes to a Decreased Sensitivity of Myeloma Cells to Bortezomib(2012)
Authors: Dehui Xu, Jinsong Hu, E Van Valckenborgh
Pages: 1840-1840 - Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.(2012)
Authors: Dehui Xu, Jinsong Hu, E Van Valckenborgh
Pages: 518-524 - Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway(2012)
Authors: Song Xu, Holly R. Evans, Clive H. Buckle, Jinsong Hu, Dehui Xu, Isabelle Vande Broek, Xavier Leleu, Benjamin Van Camp, Peter I. Croucher
Pages: 2546-2549 - Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model.(2012)
Authors: E Van Valckenborgh, W Matsui, P. Agarwal, Susanne Lub, Dehui Xu, Christophe Empsen, J Agarwal, Q. Wang, Helena Jernberg-Wiklund
Pages: 1436-1439 - Activation of ATF4 mediates the unwanted Mcl-1accumulation by proteasome inhibition.(2011)
Authors: Jinsong Hu, Nana Dang, Dehui Xu, Benjamin Van Camp, E Van Valckenborgh
Pages: 826-837 - Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM cell proliferation(2011)
Authors: Dehui Xu, Jinsong Hu, Benjamin Van Camp, E Van Valckenborgh
Pages: 1402-1405